United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
542.66
-0.73 (-0.13%)
At close: Jun 26, 2026, 4:00 PM EDT
542.50
-0.16 (-0.03%)
After-hours: Jun 26, 2026, 6:27 PM EDT
United Therapeutics Stock Forecast
Stock Price Forecast
The 13 analysts with 12-month price forecasts for United Therapeutics stock have an average target of 663.38, with a low estimate of 516 and a high estimate of 738. The average target predicts an increase of 22.25% from the current stock price of 542.66.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for United Therapeutics stock from 15 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 9 | 9 | 9 | 9 | 9 |
| Buy | 1 | 1 | 1 | 2 | 3 | 3 |
| Hold | 5 | 4 | 4 | 4 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 14 | 15 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy Reiterates $700 | Buy | Reiterates | $700 | +28.99% | Jun 12, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $516 | Hold | Maintains | $516 | -4.91% | Jun 5, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $660 | Buy | Maintains | $660 | +21.62% | May 29, 2026 |
Unknown Analyst J.P. Morgan No rating | J.P. Morgan | Buy Maintains $685 | Buy | Maintains | $685 | +26.23% | May 20, 2026 |
| Jefferies | Jefferies | Buy Maintains $668 → $733 | Buy | Maintains | $668 → $733 | +35.08% | May 19, 2026 |
Financial Forecast
Revenue This Year
3.26B
from 3.18B
Increased by 2.55%
Revenue Next Year
3.70B
from 3.26B
Increased by 13.35%
EPS This Year
27.17
from 27.86
Decreased by -2.49%
EPS Next Year
31.77
from 27.17
Increased by 16.96%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 3.4B | 4.3B | |
| Avg | 3.3B | 3.7B | |
| Low | 3.1B | 3.1B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 7.8% | 32.0% | |
| Avg | 2.6% | 13.3% | |
| Low | -1.5% | -5.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 32.68 | 38.60 | |
| Avg | 27.17 | 31.77 | |
| Low | 24.93 | 23.10 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 17.3% | 42.1% | |
| Avg | -2.5% | 17.0% | |
| Low | -10.5% | -15.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.